К содержанию
РецензированоEN2024

WHEN USING PROGRAM CHEMOTHERAPY IN PATIENTS WITH HEMOBLASTOSES, THE INCIDENCE AND STRUCTURE OF INFECTIOUS COMPLICATIONS

Эгамова С.К

НАУЧНО-ПРАКТИЧЕСКИЙ ЖУРНАЛ АННАЛЫ КЛИНИЧЕСКИХ ДИСЦИПЛИН · 2024

Аннотация

Cytostatic therapy for tumors of the blood system is associated with a high risk of developing infectious complications, the frequency of which is 80% or more, especially in the first stages of treatment. The purpose of our study was to dynamically study the incidence, spectrum and structure of infectious complications in patients with various forms of hematological malignancies at different stages of chemotherapy in one hematology hospital and to assess their impact on the overall effectiveness of treatment.

Доказательный фрагмент

«Cytostatic therapy for tumors of the blood system is associated with a high risk of developing infectious complications, the frequency of which is 80% or more, especially in the first stages of treatment.»

Образец извлечения

Демо-превью

Cytostatic therapy for tumors of the blood system is associated with a high risk of developing infectious complications, the frequency of which is 80% or more, especially in the first stages of treatment. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники

[4]МедицинаRUРецензированоОткрытый доступ
BIOGEN ELEMENTLARNING INSON SALOMATLIGIDAGI O’RNI

Медицина, педагогика и технологии: теория и практикаТЕОРИЯ И ПРАКТИКА, Ne’matova F.O. +12024

5